论文部分内容阅读
随机选取2012年9月~2013年6月我院结核科收治的80例复治涂阳肺结核患者,随机分为对照组和治疗组各40例,对照组采取肺结核强化期治疗,治疗组采用左氧氟沙星联合抗结核化疗方案,对比两组疗效及安全性。结果治疗组的总有效率(85.00%)明显好于对照组的总有效率(47.50%),具有统计学意义(P<0.05)。治疗组患者不良反应发生率为12.5%,明显低于对照组的52.5%,具有统计学意义(P<0.05)。采用左氧氟沙星联合抗结核化疗方案在治疗复治涂阳肺结核上有显著的疗效,且无其他并发症,安全性高,可以广泛的应用于临床治疗上。
Randomly selected 80 cases of retreatment smear positive pulmonary tuberculosis treated in our hospital from 2012.12 to 2013.6 were randomly divided into control group and treatment group, 40 cases in each group. The control group was treated with intensive pulmonary tuberculosis. The treatment group was treated with levofloxacin Combination of anti-tuberculosis chemotherapy, the two groups were compared efficacy and safety. Results The total effective rate (85.00%) in the treatment group was significantly better than that in the control group (47.50%), with statistical significance (P <0.05). The incidence of adverse reactions in the treatment group was 12.5%, which was significantly lower than that in the control group (52.5%), with statistical significance (P <0.05). Levofloxacin combined with anti-tuberculosis chemotherapy regimen in the treatment of smear-positive pulmonary tuberculosis have a significant effect, and no other complications, high safety, can be widely used in clinical treatment.